Janux Therapeutics News

Janux Therapeutics (JANX.US) was first covered by JoneStrading, giving it a buy rating, with a target price of $70.00.

Zhitong FinanceApr 16 18:51

Janux Therapeutics Analyst Ratings

BenzingaApr 16 18:49

Buy Rating Affirmed for Janux Therapeutics on Innovative Oncology Treatments and M&A Potential

TipRanksApr 16 04:15

Analysts' Top Healthcare Picks: Humacyte (HUMA), Janux Therapeutics Inc (JANX)

TipRanksApr 11 09:10

Janux Therapeutics Analyst Ratings

BenzingaMar 21 17:58

Janux Therapeutics Analyst Ratings

BenzingaMar 20 17:22

Cantor Fitzgerald Initiates Coverage On Janux Therapeutics With Overweight Rating, Announces Price Target of $100

BenzingaMar 20 17:24

Janux Therapeutics Analyst Ratings

BenzingaMar 13 22:30

Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Janux Therapeutics Inc (JANX) and SAGE Therapeutics (SAGE)

TipRanksMar 11 18:50

Janux Therapeutics Analyst Ratings

BenzingaMar 11 18:23

Janux Therapeutics Analyst Ratings

BenzingaFeb 27 21:54

Wedbush Adjusts Janux Therapeutics' Price Target to $53 From $24; Keeps Outperform Rating

MT NewswiresFeb 27 20:40

Buy Rating Affirmed for Janux Therapeutics on Strong Clinical Data and Advanced TRACTr Platform

TipRanksFeb 27 19:27

HC Wainwright & Co. Reiterates Buy on Janux Therapeutics, Maintains $35 Price Target

BenzingaNov 13, 2023 23:44

Janux Therapeutics Analyst Ratings

BenzingaNov 13, 2023 23:43

Analysts' Top Healthcare Picks: Janux Therapeutics Inc (JANX), Madrigal Pharmaceuticals (MDGL)

TipRanksNov 13, 2023 19:40

Janux Therapeutics Analyst Ratings

BenzingaNov 8, 2023 21:54

TD Cowen Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX)

TipRanksNov 8, 2023 11:25

Janux Therapeutics Analyst Ratings

BenzingaAug 10, 2023 21:41

Janux Therapeutics Analyst Ratings

BenzingaAug 9, 2023 18:23